891 related articles for article (PubMed ID: 10500423)
1. [Familial membranoproliferative glomerulonephritis].
Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
[TBL] [Abstract][Full Text] [Related]
2. Membranoproliferative glomerulonephritis in sibs.
Söylemezoğlu O; Tinaztepe K; Bakkaloğlu A; Saatçi U
Turk J Pediatr; 1992; 34(4):211-7. PubMed ID: 1306340
[TBL] [Abstract][Full Text] [Related]
3. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.
Braun MC; West CD; Strife CF
Am J Kidney Dis; 1999 Dec; 34(6):1022-32. PubMed ID: 10585311
[TBL] [Abstract][Full Text] [Related]
4. Familial membranoproliferative glomerulonephritis.
Bakkaloglu A; Söylemezoglu O; Tinaztepe K; Saatçi U; Söylemezoglu F
Nephrol Dial Transplant; 1995; 10(1):21-4. PubMed ID: 7724023
[TBL] [Abstract][Full Text] [Related]
5. Membranoproliferative glomerulonephritis in two siblings: report and literature review.
Bogdanović RM; Dimitrijević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
Pediatr Nephrol; 2000 May; 14(5):400-5. PubMed ID: 10805468
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of type III membranoproliferative glomerulonephritis in children.
Iitaka K; Moriya S; Nakamura S; Tomonaga K; Sakai T
Pediatr Nephrol; 2002 May; 17(5):373-8. PubMed ID: 12042898
[TBL] [Abstract][Full Text] [Related]
7. Membranoproliferative glomerulonephritis with dense intramembranous alterations. A clinicopathologic study.
Lamb V; Tisher CC; McCoy RC; Robinson RR
Lab Invest; 1977 Jun; 36(6):607-17. PubMed ID: 325295
[TBL] [Abstract][Full Text] [Related]
8. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
9. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
Ozdamar SO; Gucer S; Tinaztepe K
Pediatr Nephrol; 2003 Jan; 18(1):23-8. PubMed ID: 12488986
[TBL] [Abstract][Full Text] [Related]
11. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
Licht C; Fremeaux-Bacchi V
Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
[TBL] [Abstract][Full Text] [Related]
12. A patient with membranoproliferative glomerulonephritis diagnosed by the third biopsy via endocapillary proliferative glomerulonephritis and focal membranoproliferative glomerulonephritis.
Kano K; Nishikura K; Kojima M; Yamada Y; Arisaka O; Tomita S; Shimotsuji T; Fujikawa Y; Inafuku S; Imakita M; Ueda Y
Clin Exp Nephrol; 2003 Jun; 7(2):157-62. PubMed ID: 14586735
[TBL] [Abstract][Full Text] [Related]
13. Early presentation of membranoproliferative glomerulonephritis in Arab children.
Kari JA
Saudi Med J; 2003 Feb; 24(2):157-60. PubMed ID: 12682679
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
[TBL] [Abstract][Full Text] [Related]
15. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical and morphological evaluation of primary membranoproliferative glomerulonephritis.
Wu MJ; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Hsu YH; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):34-41. PubMed ID: 8820034
[TBL] [Abstract][Full Text] [Related]
17. Type III membranoproliferative glomerulonephritis: long-term clinical and morphologic evaluation.
Strife CF; Jackson EC; McAdams AJ
Clin Nephrol; 1984 Jun; 21(6):323-34. PubMed ID: 6331934
[TBL] [Abstract][Full Text] [Related]
18. [Sibling cases of nephritis resembling membranoproliferative glomerulonephritis].
Ueda H; Isimura E; Okuno S; Maekawa K; Izumotani T; Kim M; Matsumoto N; Fukumoto S; Imanishi Y; Emoto M; Shoji T; Wanibuchi H; Inaba M; Nishizawa Y
Nihon Jinzo Gakkai Shi; 2002 May; 44(4):420-6. PubMed ID: 12073629
[TBL] [Abstract][Full Text] [Related]
19. Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children.
Davis AE; Schneeberger EE; Grupe WE; McCluskey RT
Clin Nephrol; 1978 May; 9(5):184-93. PubMed ID: 657595
[TBL] [Abstract][Full Text] [Related]
20. [Prominent subepithelial deposits detected on 2nd renal biopsy in a boy with membranoproliferative glomerulonephritis type I: a case report].
Motoyama O; Ohshima M; Kawamura S; Iitaka K
Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):247-52. PubMed ID: 7602812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
